Compound class:
Synthetic organic
Comment: T.14 is a dual action compound that acts as an inhibitor of VEGFR2 (KDR) and the PD-L1 protein [1]. Functionally it has antiangiogenic and immunomodulator actions, that are indicative of experimental anti-tumour potential.
|
|
Immunopharmacology Comments |
The action of T.14 in inhibiting formation of the immune inhibitory PD-1/PD-L1 complex underlies its immunomodulatory effects. |